Fineline Cube

Follow:
14422 Articles
iFlytek's Subsidiary Xunfei Healthcare Technologies Lists on HKEX, Raises Over HKD 580 Million
CompanyDeals

iFlytek’s Subsidiary Xunfei Healthcare Technologies Lists on HKEX, Raises Over HKD 580 Million

Chengdu Kanghua Biological Receives NMPA Approval for Recombinant Norovirus Vaccine
CompanyDrug

Chengdu Kanghua Biological Receives NMPA Approval for Recombinant Norovirus Vaccine

Sinocare Inc's TRUE VIE CGMS Advances to 510(k) Substantive Review Stage at FDA
CompanyMedical Device

Sinocare Inc’s TRUE VIE CGMS Advances to 510(k) Substantive Review Stage at FDA

Huadong Medicine's HDM1005 Receives FDA Clearance for Heart Failure and Obesity Clinical Trial
CompanyDrug

Huadong Medicine’s HDM1005 Receives FDA Clearance for Heart Failure and Obesity Clinical Trial

Jiangsu Hengrui Pharmaceuticals Gets NMPA Approval for SHR-1501 Combo in Bladder Cancer
CompanyDrug

Jiangsu Hengrui Pharmaceuticals Gets NMPA Approval for SHR-1501 Combo in Bladder Cancer

Sino Biopharmaceutical's Benmelstobart Meets Primary Endpoint in Phase III NSCLC Study
CompanyDrug

Sino Biopharmaceutical’s Benmelstobart Meets Primary Endpoint in Phase III NSCLC Study

Hansoh Pharmaceutical Secures Global Licensing Deal with Merck for HS-10535
CompanyDeals

Hansoh Pharmaceutical Secures Global Licensing Deal with Merck for HS-10535

Ascletis Pharma's ASC47 Outperforms Semaglutide in Weight Loss Study
R&D

Ascletis Pharma’s ASC47 Outperforms Semaglutide in Weight Loss Study

UCB's Minzasolmin Fails to Meet Endpoints in ORCHESTRA Study for Early Parkinson's
CompanyDrug

UCB’s Minzasolmin Fails to Meet Endpoints in ORCHESTRA Study for Early Parkinson’s

HealthyWay Inc. Completes HKD 220 Million IPO on the Hong Kong Stock Exchange
CompanyDeals

HealthyWay Inc. Completes HKD 220 Million IPO on the Hong Kong Stock Exchange

Sino Biopharmaceutical and Sinopharm Group Collaborate to Expand Retail Pharmacy Network
CompanyDeals

Sino Biopharmaceutical and Sinopharm Group Collaborate to Expand Retail Pharmacy Network

Everest Medicines' Velsipity (Etrasimod) Receives First Prescription in Foshan under GBA Policy
CompanyDrug

Everest Medicines’ Velsipity (Etrasimod) Receives First Prescription in Foshan under GBA Policy